<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-24527" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Bullous Systemic Lupus Erythematosus</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Odonwodo</surname>
            <given-names>Amaka</given-names>
          </name>
          <aff>University Of Cincinnati</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Vashisht</surname>
            <given-names>Priyanka</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Amaka Odonwodo declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Priyanka Vashisht declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>22</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-24527.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Bullous systemic lupus erythematosus (BSLE) is a rare manifestation of systemic lupus erythematosus. It has clinical and histological features that may lead to misdiagnosis and delayed treatment of this easily treatable condition. This activity reviews the evaluation and management of bullous systemic lupus erythematosus and highlights the role of the interprofessional team in improving care for patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Outline the typical presentation of a patient with bullous systemic lupus erythematosus.</p></list-item><list-item><p>Describe the histopathology and immunopathology of bullous systemic lupus erythematosus.</p></list-item><list-item><p>Summarize management options available for bullous systemic lupus erythematosus.</p></list-item><list-item><p>Review the importance of improving care coordination amongst the interprofessional team members to improve outcomes for patients affected by bullous systemic lupus erythematosus.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24527&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24527">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-24527.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Lupus erythematosus is an autoimmune disease that has an array of clinical manifestations ranging from cutaneous to multi-organ systemic involvement. Bullous systemic lupus erythematosus (BSLE) is a rare blistering eruption seen in patients with systemic lupus erythematosus (SLE) described mainly in case reports, series, and a few multicenter retrospective studies. These cutaneous lesions appear as tense, vesiculobullous eruptions with a predilection for the extremities, trunk, face, and neck, usually healing without scar or milia.<xref ref-type="bibr" rid="article-24527.r1">[1]</xref><xref ref-type="bibr" rid="article-24527.r2">[2]</xref></p>
      </sec>
      <sec id="article-24527.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of bullous systemic lupus erythematosus is unknown. It is an uncommon complication of SLE with autoantibodies to the dermo-epidermal junction of type VII collagen. Most patients with BSLE have an existing diagnosis of SLE, although there are several reports of BSLE as an initial presentation of SLE.<xref ref-type="bibr" rid="article-24527.r2">[2]</xref><xref ref-type="bibr" rid="article-24527.r3">[3]</xref></p>
      </sec>
      <sec id="article-24527.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Bullous systemic lupus erythematosus, in line with the epidemiology of SLE, affects more females than males, usually of African descent in the second to the fourth decade of life. Nevertheless, it can be seen in all races, ages, or males. The reported incidence is limited but estimated at ~2% of all subepidermal autoimmune bullous cutaneous conditions.<xref ref-type="bibr" rid="article-24527.r4">[4]</xref><xref ref-type="bibr" rid="article-24527.r5">[5]</xref></p>
      </sec>
      <sec id="article-24527.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Autoantibodies to type VII collagen are involved in the pathophysiology of bullous systemic lupus erythematosus. This results in a weakened basement membrane-dermal adhesion, which appears as subepidermal blistering. Type VII collagen plays a vital role as an anchoring fibril attaching the epidermis to the dermis. The circulating autoantibodies are directed against the non-collagenous domain type 1 and 2 (NC1 and NC2) of type VII collagen seen in the basement membrane zone.<xref ref-type="bibr" rid="article-24527.r2">[2]</xref><xref ref-type="bibr" rid="article-24527.r6">[6]</xref>&#x000a0;Other autoantibodies have been identified, such as&#x000a0;BPAg1, laminin 5, laminin 6, and BPAg2.<xref ref-type="bibr" rid="article-24527.r7">[7]</xref></p>
      </sec>
      <sec id="article-24527.s6" sec-type="Histopathology">
        <title>Histopathology</title>
        <p>The histopathology of bullous systemic lupus erythematosus demonstrates subepidermal blistering with a dense neutrophilic infiltration in the upper dermis concentrated on the papillary tip with the association of nuclear dust and fibrin. These findings have a similarity to the histology of dermatitis herpetiformis. However, a good distinguishing feature is the presence of large deposits of mucin in the reticular dermis.<xref ref-type="bibr" rid="article-24527.r8">[8]</xref><xref ref-type="bibr" rid="article-24527.r9">[9]</xref></p>
        <p>Direct immunofluorescence (DIF) staining of perilesional and uninvolved skin shows the deposition of immune-reactants along the dermato-epidermal junction (DEJ). IgG constitutes the majority of immunoglobulins, but other classes such as IgA and IgM are seen. Complements are frequently seen in the involved skin. Granular, linear, or a mixed pattern of immune reactant deposition are seen in the basement membrane zone (BMZ). Indirect immunofluorescence staining performed with basement membrane zone-split skin may also be positive for antibodies to type VII collagen on the dermal side.<xref ref-type="bibr" rid="article-24527.r9">[9]</xref>&#x000a0;IgG subtyping can help differentiate the two.<xref ref-type="bibr" rid="article-24527.r10">[10]</xref></p>
      </sec>
      <sec id="article-24527.s7" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Bullous systemic lupus erythematosus is often an acute onset presentation with tense vesicles and bullae over erythematous or normal skin. These blisters appear more in sun-exposed areas but can be seen in non-sun-exposed skin and mucosa with a predilection for the trunk, face, neck, vermillion border, upper extremities-extensor surfaces, supraclavicular region, and oral mucosa.<xref ref-type="bibr" rid="article-24527.r4">[4]</xref><xref ref-type="bibr" rid="article-24527.r11">[11]</xref></p>
        <p>A rare pattern, erythema gyratum repens described as a centrifugally migrating erythematous plaque, has been described.<xref ref-type="bibr" rid="article-24527.r12">[12]</xref><xref ref-type="bibr" rid="article-24527.r13">[13]</xref></p>
        <p>BSLE may be associated with urticarial lesions, and pruritus is not always present. Healing with milia and/or scarring occurs infrequently. However, hypo/hyperpigmentation of the affected skin is usually seen.<xref ref-type="bibr" rid="article-24527.r8">[8]</xref></p>
        <p>Several reports have shown an association with BSLE and active lupus nephritis. A multicenter retrospective study and literature review with a total of 128 cases described lupus nephritis in 50% of the cases, mainly class III or IV. 7% of cases had neuropsychiatric SLE and 45% with hematologic involvement at the time of BSLE.<xref ref-type="bibr" rid="article-24527.r8">[8]</xref></p>
      </sec>
      <sec id="article-24527.s8" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>A careful review of the clinical presentation, serologies, histology, and immunofluorescence is required in the process of diagnosis.</p>
        <p>In 1983 Camisa and Sharma proposed the following diagnostic criteria for bullous systemic lupus erythematosus, which was later revised in 1986:<xref ref-type="bibr" rid="article-24527.r14">[14]</xref><xref ref-type="bibr" rid="article-24527.r15">[15]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>A diagnosis of SLE based on the American College of Rheumatology (ACR) criteria</p>
          </list-item>
          <list-item>
            <p>Vesicles and bullae arising upon but not limited to sun-exposed skin</p>
          </list-item>
          <list-item>
            <p>Histopathology compatible with dermatitis herpetiformis (DH)</p>
          </list-item>
          <list-item>
            <p>Negative or positive indirect immunofluorescence (IIF) for circulating BMZ autoantibodies</p>
          </list-item>
          <list-item>
            <p>Direct immunofluorescence (DIF) revealing IgG and/or IgM and often IgA at the BMZ</p>
          </list-item>
        </list>
        <p>In 1995, Yell et al. l described BSLE as "an acquired subepidermal blistering disease in a patient with SLE with immune reactants at the BMZ on either DIF or IIF."<xref ref-type="bibr" rid="article-24527.r11">[11]</xref></p>
        <p>Detection of an autoantibody directed against collagen VII was shown to play a role in BSLE. The criteria by Camisa and Sharma were made before the availability of ELISA or immunoblot technology. The use of ELISA for detecting antibodies against NC1 and NC2 of type VII collagen is utilized.<xref ref-type="bibr" rid="article-24527.r16">[16]</xref></p>
        <p>However, it is important to note that a diagnosis of SLE is usually present; however, this may be the first presentation of SLE in a few cases. A thorough exclusion of other blistering diseases should also be completed.</p>
      </sec>
      <sec id="article-24527.s9" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Dapsone is considered the first line of treatment with a good response.<xref ref-type="bibr" rid="article-24527.r17">[17]</xref></p>
        <p>The use of dapsone, however, may have a few side effects, including but not limited to anemia, hepatitis, or hypersensitivity syndrome. In the event of intolerance, systemic manifestation, or extensive skin involvement, the use of steroids may be considered.</p>
        <p>Several steroid-sparing agents have been used in the literature with variable efficacy. These immunosuppressive medications include cyclophosphamide, azathioprine, mycophenolate mofetil, methotrexate, with modest results. Rituximab has shown some promise with refractory cases.</p>
        <p>Less infrequently, anakinra and intravenous immunoglobulins have been reported.<xref ref-type="bibr" rid="article-24527.r8">[8]</xref></p>
      </sec>
      <sec id="article-24527.s10" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Bullous systemic lupus erythematosus may be confused with several other blistering diseases, especially two autoimmune blistering conditions: dermatitis herpetiformis (DH) or epidermolysis bullosa acquisita (EBA).</p>
        <p>Epidermolysis bullosa acquisita (EBA) exhibits similar antibodies against type VII collagen. It is more likely to heal with scarring and milia formation compared to BSLE. A prominent distinguishing feature includes the absence of SLE and a lack of histologic finding of large deposits of mucin in the dermis. The poor or slow response to dapsone in EBA compared to BSLE may help in separating the two entities.</p>
        <p>Dermatitis herpetiformis (DH) has a skin distribution different from BSLE. The pruritic lesions have a predilection to the extensor surfaces, elbows, knees, and buttocks. DH is histologically identical to BSLE except for the presence of IgA deposition within the dermal papilla.<xref ref-type="bibr" rid="article-24527.r18">[18]</xref></p>
        <p>Other differential diagnoses include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Linear IgA bullous dermatosis: immunofluorescence shows IgA deposition on the epidermal side of split skin</p>
          </list-item>
          <list-item>
            <p>Systemic lupus erythematosus with blisters</p>
          </list-item>
          <list-item>
            <p>Bullous pemphigoid: With the aid of immunofluorescence, antibody deposition is found on the epidermal side of salt-split skin</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24527.s11" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>In a 12-year retrospective review, the majority of the patients healed without scarring or milia, although post-inflammatory hypo- or hyper-pigmentation may be seen. It was also pointed out that BSLE rarely recurred.<xref ref-type="bibr" rid="article-24527.r19">[19]</xref></p>
      </sec>
      <sec id="article-24527.s12" sec-type="Complications">
        <title>Complications</title>
        <p>Complications include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Infection of exposed and affected skin</p>
          </list-item>
          <list-item>
            <p>Sloughing esophagitis</p>
          </list-item>
          <list-item>
            <p>Complications from concomitant multiorgan SLE flare</p>
          </list-item>
          <list-item>
            <p>Medication side effects</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-24527.s13" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education is very vital in the management of bullous systemic lupus erythematosus. For a few, this may present as the first manifestation of SLE, which is a chronic, autoimmune condition with several multiorgan involvements. Educate these patients on the early signs and symptoms of organ involvement, photoprotection with sunscreen, and the need for medication adherence.</p>
        <p>BSLE poses significant stress related to discomfort, aesthetics, and concern of skin complications. Support groups and behavioral therapy may be needed in such cases.</p>
      </sec>
      <sec id="article-24527.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional approach in evaluation, treatment, and care of patients with bullous systemic lupus erythematosus cannot be over-emphasized.</p>
        <p>Primary care physicians, rheumatologists, and dermatologists play a key role in early diagnosis. The histopathology mimics of BSLE can be a source of a wrong diagnosis and delay of treatment, thus the need for an experienced pathologist.</p>
        <p>Skincare by trained and dedicated nurses of the skin lesions, especially when ruptured leaving behind crusts and erosions, is also important.</p>
        <p>Clinicians, nurses, and pharmacists also need to educate their patients on the disease condition, medications, and their potential side effects.</p>
        <p>In cases with concomitant lupus nephritis, neuropsychiatric lupus, and hematologic complications, other subspecialties such as nephrology, neurology, and hematology may be needed.</p>
        <p>Most importantly, the patient and family need to be involved in the treatment strategies, especially on decisions to escalate treatment to immunosuppressants. [Level 5]</p>
      </sec>
      <sec id="article-24527.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=24527&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=24527">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/bullous-systemic-lupus-erythematosus/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=24527">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/24527/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=24527">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-24527.s16">
        <fig id="article-24527.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Bullous SLE Contributed by Priyanka Vashisht MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pic__3" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24527.s17">
        <fig id="article-24527.image.f2" position="float" orientation="portrait">
          <caption>
            <p>Bullous SLE Contributed by Priyanka Vashisht MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="pic__2" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <floats-group id="article-24527.s18">
        <fig id="article-24527.image.f3" position="float" orientation="portrait">
          <caption>
            <p>Bullous SLE Contributed by Priyanka Vashisht MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="BSLE__picture" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-24527.s19">
        <title>References</title>
        <ref id="article-24527.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rutnin</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chanprapaph</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Vesiculobullous diseases in relation to lupus erythematosus.</article-title>
            <source>Clin Cosmet Investig Dermatol</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>653</fpage>
            <page-range>653-667</page-range>
            <pub-id pub-id-type="pmid">31564947</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Contestable</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Edhegard</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Meyerle</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Bullous systemic lupus erythematosus: a review and update to diagnosis and treatment.</article-title>
            <source>Am J Clin Dermatol</source>
            <year>2014</year>
            <month>Dec</month>
            <volume>15</volume>
            <issue>6</issue>
            <fpage>517</fpage>
            <page-range>517-24</page-range>
            <pub-id pub-id-type="pmid">25358414</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tincopa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Puttgen</surname>
                <given-names>KB</given-names>
              </name>
              <name>
                <surname>Sule</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>BA</given-names>
              </name>
              <name>
                <surname>Gerstenblith</surname>
                <given-names>MR</given-names>
              </name>
            </person-group>
            <article-title>Bullous lupus: an unusual initial presentation of systemic lupus erythematosus in an adolescent girl.</article-title>
            <source>Pediatr Dermatol</source>
            <year>2010</year>
            <season>Jul-Aug</season>
            <volume>27</volume>
            <issue>4</issue>
            <fpage>373</fpage>
            <page-range>373-6</page-range>
            <pub-id pub-id-type="pmid">20653856</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anyanwu</surname>
                <given-names>CO</given-names>
              </name>
              <name>
                <surname>Ang</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Werth</surname>
                <given-names>VP</given-names>
              </name>
            </person-group>
            <article-title>Oral mucosal involvement in bullous lupus.</article-title>
            <source>Arthritis Rheum</source>
            <year>2013</year>
            <month>Oct</month>
            <volume>65</volume>
            <issue>10</issue>
            <fpage>2622</fpage>
            <pub-id pub-id-type="pmid">23780804</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bernard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Vaillant</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Labeille</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Bedane</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arbeille</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Denoeux</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Lorette</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bonnetblanc</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Prost</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.</article-title>
            <source>Arch Dermatol</source>
            <year>1995</year>
            <month>Jan</month>
            <volume>131</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-52</page-range>
            <pub-id pub-id-type="pmid">7826096</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bain</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Grover</surname>
                <given-names>RK</given-names>
              </name>
              <name>
                <surname>Plunkett</surname>
                <given-names>RW</given-names>
              </name>
              <name>
                <surname>Beutner</surname>
                <given-names>EH</given-names>
              </name>
            </person-group>
            <article-title>Detection of collagen VII autoantibodies to NC1 and NC2 domains of collagen VII by ELISA in suspected epidermolysis bullosa acquisita and bullous lupus erythematosus patients.</article-title>
            <source>J Dermatol Sci</source>
            <year>2012</year>
            <month>Feb</month>
            <volume>65</volume>
            <issue>2</issue>
            <fpage>155</fpage>
            <page-range>155-6</page-range>
            <pub-id pub-id-type="pmid">22225828</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chan</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Lapiere</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Traczyk</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mancini</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Paller</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Woodley</surname>
                <given-names>DT</given-names>
              </name>
              <name>
                <surname>Marinkovich</surname>
                <given-names>MP</given-names>
              </name>
            </person-group>
            <article-title>Bullous systemic lupus erythematosus with autoantibodies recognizing multiple skin basement membrane components, bullous pemphigoid antigen 1, laminin-5, laminin-6, and type VII collagen.</article-title>
            <source>Arch Dermatol</source>
            <year>1999</year>
            <month>May</month>
            <volume>135</volume>
            <issue>5</issue>
            <fpage>569</fpage>
            <page-range>569-73</page-range>
            <pub-id pub-id-type="pmid">10328198</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Risi-Pugliese</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Cohen Aubart</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Haroche</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Moguelet</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Grootenboer-Mignot</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mathian</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ingen-Housz-Oro</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hie</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wendremaire</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Aucouturier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Lepelletier</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Miyara</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bader-Meunier</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>R&#x000e9;my</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fabien</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Franc&#x000e8;s</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barete</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Amoura</surname>
                <given-names>Z</given-names>
              </name>
            </person-group>
            <article-title>Clinical, histological, immunological presentations and outcomes of bullous systemic lupus erythematosus: 10 New cases and a literature review of 118 cases.</article-title>
            <source>Semin Arthritis Rheum</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>48</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <page-range>83-89</page-range>
            <pub-id pub-id-type="pmid">29191376</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vassileva</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Bullous systemic lupus erythematosus.</article-title>
            <source>Clin Dermatol</source>
            <year>2004</year>
            <season>Mar-Apr</season>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>129</fpage>
            <page-range>129-38</page-range>
            <pub-id pub-id-type="pmid">15234014</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Gual</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Guilabert</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Iranzo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Flores</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Diaz</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Mascar&#x000f3;</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>IgG autoantibody subclass analysis as a tool to differentiate epidermolysis bullosa acquisita with overlapping features of bullous systemic lupus erythematosus.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2013</year>
            <month>Jul</month>
            <volume>69</volume>
            <issue>1</issue>
            <fpage>e34</fpage>
            <page-range>e34-6</page-range>
            <pub-id pub-id-type="pmid">23768307</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yell</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wojnarowska</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kirtschig</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Burge</surname>
                <given-names>SM</given-names>
              </name>
            </person-group>
            <article-title>Bullous systemic lupus erythematosus: revised criteria for diagnosis.</article-title>
            <source>Br J Dermatol</source>
            <year>1995</year>
            <month>Jun</month>
            <volume>132</volume>
            <issue>6</issue>
            <fpage>921</fpage>
            <page-range>921-8</page-range>
            <pub-id pub-id-type="pmid">7662571</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fruchter</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Shaikh</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Myers</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Eungdamrong</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Franks</surname>
                <given-names>AG</given-names>
              </name>
            </person-group>
            <article-title>An erythema gyratum repens variant of bullous lupus erythematosus.</article-title>
            <source>JAAD Case Rep</source>
            <year>2016</year>
            <month>Mar</month>
            <volume>2</volume>
            <issue>2</issue>
            <fpage>111</fpage>
            <page-range>111-3</page-range>
            <pub-id pub-id-type="pmid">27051846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Da Silva Sousa</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Campos</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Oliveira</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Menezes</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tente</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baptista</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Bullous lupus erythematosus with an erythema gyratum repens-like pattern.</article-title>
            <source>Dermatol Online J</source>
            <year>2019</year>
            <month>Jan</month>
            <day>15</day>
            <volume>25</volume>
            <issue>1</issue>
            <pub-id pub-id-type="pmid">30710900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camisa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sharma</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Vesiculobullous systemic lupus erythematosus. Report of two cases and a review of the literature.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>1983</year>
            <month>Dec</month>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>924</fpage>
            <page-range>924-33</page-range>
            <pub-id pub-id-type="pmid">6358284</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Camisa</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Grimwood</surname>
                <given-names>RE</given-names>
              </name>
            </person-group>
            <article-title>Indirect immunofluorescence in vesiculobullous eruption of systemic lupus erythematosus.</article-title>
            <source>J Invest Dermatol</source>
            <year>1986</year>
            <month>May</month>
            <volume>86</volume>
            <issue>5</issue>
            <fpage>606</fpage>
            <pub-id pub-id-type="pmid">3528314</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Komorowski</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>M&#x000fc;ller</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Vorobyev</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Probst</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Recke</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jonkman</surname>
                <given-names>MF</given-names>
              </name>
              <name>
                <surname>Hashimoto</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SC</given-names>
              </name>
              <name>
                <surname>Groves</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Ludwig</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Zillikens</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>St&#x000f6;cker</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Sensitive and specific assays for routine serological diagnosis of epidermolysis bullosa acquisita.</article-title>
            <source>J Am Acad Dermatol</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>68</volume>
            <issue>3</issue>
            <fpage>e89</fpage>
            <page-range>e89-95</page-range>
            <pub-id pub-id-type="pmid">22341608</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Treatment of Bullous Systemic Lupus Erythematosus.</article-title>
            <source>J Immunol Res</source>
            <year>2015</year>
            <volume>2015</volume>
            <fpage>167064</fpage>
            <pub-id pub-id-type="pmid">26090480</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ko</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Colegio</surname>
                <given-names>OR</given-names>
              </name>
              <name>
                <surname>Moss</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>McNiff</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Fibrillar IgA deposition in dermatitis herpetiformis--an underreported pattern with potential clinical significance.</article-title>
            <source>J Cutan Pathol</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>37</volume>
            <issue>4</issue>
            <fpage>475</fpage>
            <page-range>475-7</page-range>
            <pub-id pub-id-type="pmid">19919655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-24527.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chanprapaph</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sawatwarakul</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vachiramon</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients.</article-title>
            <source>Lupus</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>26</volume>
            <issue>12</issue>
            <fpage>1278</fpage>
            <page-range>1278-1284</page-range>
            <pub-id pub-id-type="pmid">28358242</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
